Jubilant HollisterStier LLC, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in the United States. Founded in 2007, the company has established itself as a leader in contract manufacturing and development services, specialising in sterile injectables, solid dose forms, and complex formulations. With operational facilities across North America, Jubilant HollisterStier is renowned for its commitment to quality and innovation. The company’s core offerings include comprehensive drug development, manufacturing, and packaging solutions, tailored to meet the unique needs of its clients. Notable achievements include securing multiple regulatory approvals and expanding its capabilities to support a diverse range of therapeutic areas. As a trusted partner in the industry, Jubilant HollisterStier continues to enhance its market position through strategic investments and a focus on customer-centric solutions.
How does Jubilant HollisterStier LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jubilant HollisterStier LLC's score of 52 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jubilant HollisterStier LLC, headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Jubilant Pharmova Limited, which may influence its climate commitments and reporting practices. As of now, Jubilant HollisterStier LLC has not established any documented reduction targets or climate pledges. The absence of specific initiatives or targets suggests that the company may be in the early stages of developing its climate strategy or may rely on the broader commitments of its parent organisation. The emissions data and climate initiatives of Jubilant HollisterStier LLC are cascaded from Jubilant Pharmova Limited, which operates at a higher corporate level. This relationship may provide a framework for future emissions reporting and climate action, although specific details on emissions or targets from Jubilant Pharmova Limited are not provided in the current context. In summary, while Jubilant HollisterStier LLC does not present specific emissions data or reduction targets at this time, its affiliation with Jubilant Pharmova Limited may play a crucial role in shaping its future climate commitments and sustainability initiatives.
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 894,456,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 107,906,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 12,057,000 | - | - | - | 00,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Jubilant HollisterStier LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.